Table of Contents

2018-2023 Global Alfuzosin Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Alfuzosin Consumption 2013-2023
  • 2.1.2 Alfuzosin Consumption CAGR by Region
• 2.2 Alfuzosin Segment by Type
  • 2.2.1 2.5mg Tablets
  • 2.2.2 10mg Tablets
• 2.3 Alfuzosin Consumption by Type
  • 2.3.1 Global Alfuzosin Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Alfuzosin Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Alfuzosin Sale Price by Type (2013-2018)
• 2.4 Alfuzosin Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug store
• 2.5 Alfuzosin Consumption by Application
  • 2.5.1 Global Alfuzosin Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Alfuzosin Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Alfuzosin Sale Price by Application (2013-2018)

3 Global Alfuzosin by Players

• 3.1 Global Alfuzosin Sales Market Share by Players
  • 3.1.1 Global Alfuzosin Sales by Players (2016-2018)
  • 3.1.2 Global Alfuzosin Sales Market Share by Players (2016-2018)
• 3.2 Global Alfuzosin Revenue Market Share by Players
  • 3.2.1 Global Alfuzosin Revenue by Players (2016-2018)
  • 3.2.2 Global Alfuzosin Revenue Market Share by Players (2016-2018)
• 3.3 Global Alfuzosin Sale Price by Players
• 3.4 Global Alfuzosin Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Alfuzosin Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Alfuzosin Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Alfuzosin by Regions

• 4.1 Alfuzosin by Regions
  • 4.1.1 Global Alfuzosin Consumption by Regions
  • 4.1.2 Global Alfuzosin Value by Regions
• 4.2 Americas Alfuzosin Consumption Growth
• 4.3 APAC Alfuzosin Consumption Growth
• 4.4 Europe Alfuzosin Consumption Growth
• 4.5 Middle East & Africa Alfuzosin Consumption Growth

5 Americas

• 5.1 Americas Alfuzosin Consumption by Countries
  • 5.1.1 Americas Alfuzosin Consumption by Countries (2013-2018)
  • 5.1.2 Americas Alfuzosin Value by Countries (2013-2018)
• 5.2 Americas Alfuzosin Consumption by Type
• 5.3 Americas Alfuzosin Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Alfuzosin Consumption by Countries
  • 6.1.1 APAC Alfuzosin Consumption by Countries (2013-2018)
  • 6.1.2 APAC Alfuzosin Value by Countries (2013-2018)
• 6.2 APAC Alfuzosin Consumption by Type
• 6.3 APAC Alfuzosin Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Alfuzosin by Countries
  • 7.1.1 Europe Alfuzosin Consumption by Countries (2013-2018)
  • 7.1.2 Europe Alfuzosin Value by Countries (2013-2018)
• 7.2 Europe Alfuzosin Consumption by Type
• 7.3 Europe Alfuzosin Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Alfuzosin by Countries
  • 8.1.1 Middle East & Africa Alfuzosin Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Alfuzosin Value by Countries (2013-2018)
• 8.2 Middle East & Africa Alfuzosin Consumption by Type
• 8.3 Middle East & Africa Alfuzosin Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Alfuzosin Distributors
• 10.3 Alfuzosin Customer

11 Global Alfuzosin Market Forecast

• 11.1 Global Alfuzosin Consumption Forecast (2018-2023)
• 11.2 Global Alfuzosin Forecast by Regions
  • 11.2.1 Global Alfuzosin Forecast by Regions (2018-2023)
  • 11.2.2 Global Alfuzosin Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Alfuzosin Forecast by Type
• 11.8 Global Alfuzosin Forecast by Application

12 Key Players Analysis

• 12.1 Mylan
  • 12.1.1 Company Details
  • 12.1.2 Alfuzosin Product Offered
  • 12.1.3 Mylan Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Mylan News
• 12.2 Teva
  • 12.2.1 Company Details
  • 12.2.2 Alfuzosin Product Offered
  • 12.2.3 Teva Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Teva News
• 12.3 Apotex
  • 12.3.1 Company Details
  • 12.3.2 Alfuzosin Product Offered
  • 12.3.3 Apotex Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Apotex News
• 12.4 Torrent Pharmaceuticals
  • 12.4.1 Company Details
  • 12.4.2 Alfuzosin Product Offered
  • 12.4.3 Torrent Pharmaceuticals Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Torrent Pharmaceuticals News
• 12.5 Sun Pharma
  • 12.5.1 Company Details
  • 12.5.2 Alfuzosin Product Offered
  • 12.5.3 Sun Pharma Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Sun Pharma News
• 12.6 Aurobindo
  • 12.6.1 Company Details
  • 12.6.2 Alfuzosin Product Offered
  • 12.6.3 Aurobindo Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Aurobindo News
• 12.7 Wockhardt
  • 12.7.1 Company Details
  • 12.7.2 Alfuzosin Product Offered
  • 12.7.3 Wockhardt Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 Wockhardt News
• 12.8 Unichem Laboratories
  • 12.8.1 Company Details
  • 12.8.2 Alfuzosin Product Offered
  • 12.8.3 Unichem Laboratories Alfuzosin Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.8.4 Main Business Overview
  • 12.8.5 Unichem Laboratories News

13 Research Findings and Conclusion

Alfuzosin is a medication of the α1 blocker class. It is used to treat benign prostatic hyperplasia (BPH). 

According to this study, over the next five years the Alfuzosin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Alfuzosin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Alfuzosin market by product type, application, key manufacturers and key regions and countries.

This study considers the Alfuzosin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
2.5mg Tablets
10mg Tablets
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mylan
Teva
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Alfuzosin consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Alfuzosin market by identifying its various subsegments.
Focuses on the key global Alfuzosin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Alfuzosin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Alfuzosin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.